EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer

Cristian Arriaga-Canon, Laura Contreras-Espinosa, Sergio Aguilar-Villanueva, Enrique Bargalló-Rocha, José Antonio García-Gordillo iD, Paula Cabrera-Galeana, Clementina Castro-Hernández iD, Francisco Jiménez-Trejo, L A Herrera iD

International Journal of Molecular Sciences · 18.04.2023 · 24 (8) · 7426

DOI: 10.3390/ijms24087426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2023. Verfasst von Cristian Arriaga-Canon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Avenida San Fernando N…. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Programa de Posgrado en Ciencias Biológicas, UNAM, CONACYT with Currículum Vitae Único.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given their tumor-specific and stage-specific gene expression, long non-coding RNAs (lncRNAs) have demonstrated to be potential molecular biomarkers for diagnosis, prognosis, and treatment response. Particularly, the lncRNAs DSCAM-AS1 and GATA3-AS1 serve as examples of this because of their high subtype-specific expression profile in luminal B-like breast cancer. This makes them candidates to use as molecular biomarkers in clinical practice. However, lncRNA studies in breast cancer are limited in sample size and are restricted to the determination of their biological function, which represents an obstacle for its inclusion as molecular biomarkers of clinical utility. Nevertheless, due to their expression specificity among diseases, such as cancer, and their stability in body fluids, lncRNAs are promising molecular biomarkers that could improve the reliability, sensitivity, and specificity of molecular techniques used in clinical diagnosis. The development of lncRNA-based diagnostics and lncRNA-based therapeutics will be useful in routine medical practice to improve patient clinical management and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRNA, Long NoncodingHumansFemaleQuality of LifeReproducibility of ResultsBiomarkersBiomarkers, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

biomarkersbreast cancerlncRNA

Substanzen

RNA, Long NoncodingBiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Avenida San Fernando No. 22 Col. Sección XVI, Tlalpan, Mexico City C.P. 14080, Mexico.
  • Posgrado en Ciencias Biológicas, Unidad de Posgrado, Edificio D, 1° Piso, Circuito de Posgrados, Ciudad Universitaria, Coyoacán, Mexico City C.P. 04510, Mexico.
  • Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Tlalpan, Mexico City C.P. 14080, Mexico.
  • Departamento de Oncología Médica de Mama, Instituto Nacional de Cancerología, Tlalpan, Mexico City C.P. 14080, Mexico.
  • Instituto Nacional de Pediatría, Coyoacán, Mexico City C.P. 04530, Mexico.
  • Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey C.P. 64710, Mexico.

ORCID-Profile: José Antonio García-Gordillo, Clementina Castro-Hernández, L A Herrera

Förderung

  • Consejo Nacional de Ciencia y Tecnología
  • Programa de Posgrado en Ciencias Biológicas, UNAM
  • CONACYT with Currículum Vitae Único

Zitieren

APA

Arriaga-Canon, C., Contreras-Espinosa, L., Aguilar-Villanueva, S., Bargalló-Rocha, E., García-Gordillo, J. A., Cabrera-Galeana, P., Castro-Hernández, C., Jiménez-Trejo, F., & Herrera, L. A. (2023). The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer. International Journal of Molecular Sciences, 24(8), 7426. https://doi.org/10.3390/ijms24087426

Vancouver

Arriaga-Canon C, Contreras-Espinosa L, Aguilar-Villanueva S, Bargalló-Rocha E, García-Gordillo JA, Cabrera-Galeana P, et al. The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer. International Journal of Molecular Sciences. 2023;24(8):7426. doi:10.3390/ijms24087426

BibTeX
@article{ArriagaCanon2023,
  author = {Arriaga-Canon, Cristian and Contreras-Espinosa, Laura and Aguilar-Villanueva, Sergio and Bargalló-Rocha, Enrique and García-Gordillo, José Antonio and Cabrera-Galeana, Paula and Castro-Hernández, Clementina and Jiménez-Trejo, Francisco and Herrera, L A},
  title = {The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {8},
  pages = {7426},
  doi = {10.3390/ijms24087426}
}
Kostenlos starten →